X4 Pharmaceuticals, Inc (XFOR) Insider Trading -- Recent Executive & Director Transactions

11 insiders reported 17 Form 4 transactions for X4 Pharmaceuticals, Inc (XFOR) over the past 18 months (most recent 2026-08-13). Recent activity: Craig Adam R (Executive Chairman) Sell 47,436 shares, Volpone John (President) Sell 24,576 shares, KIRSKE DAVID (Chief Financial Officer) Sell 8,543 shares, KIRSKE DAVID (Chief Financial Officer) Sell 16,961 shares, Craig Adam R (Executive Chairman) Buy 86,206 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-13Craig Adam RExecutive ChairmanSell47,436$210,829
2026-08-13Volpone JohnPresidentSell24,576$109,228
2026-07-01KIRSKE DAVIDChief Financial OfficerSell8,543$36,428
2026-05-13KIRSKE DAVIDChief Financial OfficerSell16,961$72,820
2025-10-27Craig Adam RExecutive ChairmanBuy86,206$249,997
2025-08-14KIRSKE DAVIDChief Financial OfficerBuy193,254$0
2025-08-14Craig Adam RExecutive ChairmanBuy289,881$0
2025-08-14Volpone JohnPresidentBuy289,881$0
2025-07-03Thoren Natasha FayChief Legal OfficerBuy3,333$0
2025-06-10WYZGA MICHAEL SDirectorBuy1,500$0
2025-06-10Woods KeithDirectorBuy1,500$0
2025-06-10Bridger GaryDirectorBuy1,500$0
2025-06-10MCGIRR DAVID W JDirectorBuy1,500$0
2025-06-10de Craecker FrancoiseDirectorBuy1,500$0
2025-06-10Stewart MurrayDirectorBuy1,500$0
2025-06-03Baldry MarkChief Commercial OfficerBuy1,032$2,559
2025-05-20Baldry MarkChief Commercial OfficerBuy1,032$2,559

Source: SEC Form 4 filings · as of 2026-08-13